{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:37:05Z","timestamp":1770511025320,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.maturitas.2013.05.021","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T08:30:26Z","timestamp":1372667426000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis"],"prefix":"10.1016","volume":"76","author":[{"given":"Nicol\u00e1s","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"S\u00e1nchez-Borrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Villero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Bar\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Calaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Jes\u00fas","family":"Cancelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pluvio","family":"Coronado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Fern\u00e1ndez-Moya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pl\u00e1cido","family":"Llaneza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Neyro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"del Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2013.05.021_bib0005","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00198-005-1983-4","article-title":"Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50","volume":"16","author":"Naves","year":"2005","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.maturitas.2013.05.021_bib0010","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/gme.0b013e31825d65c5","article-title":"Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture","volume":"19","author":"Bar\u00f3","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3109\/09513590.2012.679062","article-title":"Recommendations on the management of fragility fracture risk in women younger than 70 years","volume":"28","author":"Palacios","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0020","unstructured":"http:\/\/cebgrade.mcmaster.ca\/."},{"key":"10.1016\/j.maturitas.2013.05.021_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0030","unstructured":"http:\/\/www.qfracture.org."},{"key":"10.1016\/j.maturitas.2013.05.021_bib0035","unstructured":"http:\/\/www.osteoed.org\/tools.php."},{"key":"10.1016\/j.maturitas.2013.05.021_bib0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-154-5-201103010-00307","article-title":"Screening for osteoporosis: recommendation statement","volume":"154","author":"US Preventive Services Task Force","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-5013(08)71087-2","article-title":"Caracter\u00edsticas epidemiol\u00f3gicas de una poblaci\u00f3n de mujeres posmenop\u00e1usicas con osteopenia y osteoporosis: importancia de la dieta mediterr\u00e1nea","volume":"51","author":"Mendoza","year":"2008","journal-title":"Progr Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0050","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1210\/jc.2011-3060","article-title":"Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis","volume":"97","author":"Murad","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.maturitas.2012.10.019","article-title":"EMAS position statement: diet and health in midlife and beyond","volume":"74","author":"Lambrinoudaki","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.maturitas.2011.11.002","article-title":"EMAS position statement: vitamin D and postmenopausal health","volume":"71","author":"P\u00e9rez-L\u00f3pez","year":"2012","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.maturitas.2013.05.021_bib0065","first-page":"CD000333","article-title":"Exercise for preventing and treating osteoporosis in postmenopausal women","author":"Howe","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00198-007-0545-3","article-title":"Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women","volume":"19","author":"Delmas","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0075","first-page":"CD004143","article-title":"Long term hormone therapy for perimenopausal and postmenopausal women","volume":"7","author":"Marjoribanks","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.maturitas.2013.02.001","article-title":"Global consensus statement on menopausal hormone therapy","volume":"74","author":"de Villiers","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.maturitas.2011.11.018","article-title":"An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis","volume":"71","author":"Komm","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.maturitas.2011.11.010","article-title":"EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis","volume":"71","author":"Palacios","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0095","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCULATIONAHA.108.817577","article-title":"Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors","volume":"119","author":"Collins","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0100","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bone.2009.02.014","article-title":"Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","article-title":"Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study","volume":"23","author":"Silverman","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-010-1302-6","article-title":"Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial","volume":"22","author":"de Villiers","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/11207810-000000000-00000","article-title":"Bazedoxifene: a guide to its use in postmenopausal osteoporosis","volume":"29","author":"Keating","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0120","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jbmr.1819","article-title":"Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women","volume":"28","author":"Hiligsmann","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.maturitas.2013.05.021_bib0125","first-page":"CD001155","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/gme.0b013e3182214f5a","article-title":"Reduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronate","volume":"19","author":"Palacios","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00198-012-2042-6","article-title":"Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges","volume":"24","author":"Solomon","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semerg.2012.07.006","article-title":"Postmenopausal osteoporosis: primary prevention or excessive use of medications","volume":"39","author":"Mendoza-Edroso","year":"2013","journal-title":"Semergen"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0145","article-title":"Systematic literature review of biphosphonates and osteonecrosis of the jaw in patients with osteoporosis","author":"Chamizo","year":"2012","journal-title":"Rheumatol Clin"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0150","series-title":"Background document for meeting of Advisory Committee for Reproductive Health Drugs and Drug Safety and Risk Management Advisory Committee","author":"Food and Drug Administration","year":"2011"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0155","unstructured":"http:\/\/www.ema.europa.eu\/ema\/index."},{"key":"10.1016\/j.maturitas.2013.05.021_bib0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00198-012-2068-9","article-title":"Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis","volume":"24","author":"Freemantle","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","article-title":"Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial","volume":"72","author":"Reginster","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0170","unstructured":"http:\/\/www.ema.europa.eu\/258269\/2013."},{"key":"10.1016\/j.maturitas.2013.05.021_bib0175","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00223-012-9587-4","article-title":"Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper","volume":"90","author":"Goldhahn","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0185","unstructured":"http:\/\/www.aemps.es."},{"key":"10.1016\/j.maturitas.2013.05.021_bib0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.maturitas.2011.09.001","article-title":"Soy isoflavones for osteoporosis: an evidence-based approach","volume":"70","author":"Taku","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0195","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.maturitas.2009.06.006","article-title":"Bazedoxifene\/conjugated estrogens and quality of life in postmenopausal women","volume":"63","author":"Utian","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0200","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s00198-011-1891-8","article-title":"Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications","volume":"23","author":"Body","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/13697137.2010.500749","article-title":"Periodontitis and osteoporosis: a systematic review","volume":"13","author":"Mart\u00ednez-Maestre M\u00c1","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.maturitas.2008.07.009","article-title":"Self-reported compliance with osteoporosis medication-qualitative aspects and correlates","volume":"60","author":"Vytrisalova","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2006.01.011","article-title":"Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety","volume":"54","author":"Epstein","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.maturitas.2003.12.006","article-title":"Postmenopausal osteoporosis and alendronate","volume":"48","author":"P\u00e9rez-L\u00f3pez","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jbspin.2011.05.001","article-title":"Monitoring of bone turnover markers does not improve persistence with ibandronate treatment","volume":"79","author":"Roux","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0230","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00198-011-1555-8","article-title":"Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic postmenopausal women","volume":"23","author":"Breuil","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0240","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0245","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis. Where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0250","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1056\/NEJMp1202623","article-title":"Continuing bisphosphonate treatment for osteoporosis \u2013 for whom and for how long?","volume":"366","author":"Black","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2013.05.021_bib0255","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/gme.0b013e31825ae17e","article-title":"Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation","volume":"19","author":"Cauley","year":"2012","journal-title":"Menopause"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512213001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512213001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:57:56Z","timestamp":1759913876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512213001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0378512213001862"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2013.05.021","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2013.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}